# 215 Capital

215 Capital is a Private Equity based in Philadelphia, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Philadelphia, United States
- **Region:** North America
- **Address:** Philadelphia, PA, United States
- **Founded:** 2016
- **Assets under management:** Undisclosed
- **Website:** www.215capital.com
- **LinkedIn:** https://www.linkedin.com/company/215-capital

## Regulatory record

- **Reports private funds:** No

## About

215 Capital is a full life-cycle investment firm with three verticals: Operations Portfolio, Incubation Platform, and Investment Fund. The firm empowers companies that find cures for deadly diseases in pharmaceuticals, healthcare and life sciences. Its team deploys clinical, commercial and operational domain expertise, capital, and resources to promising companies addressing unmet medical need.

## Sectors

- Enterprise Software
- FinTech
- Digital Health
- AI/ML

## People

- Ajay Raju — Founder
- David Cochran — Ph.D., Director, Pharma and Biotech Investments
- Ricky Yang — Chief Financial Officer
- Rob Davis — Compliance
- Ranjeesh Gopinathan — Board, Portfolios
- Rudy Karsan — Partner
- Ted Hailu — Chief Administrative Officer
- Amit Shah — Director, Pharma and Life Sciences Investments
- Jeffrey Lee — Chief Accounting Officer
- Aaron Mahdee — Operations
- Junge Zhang — Ph.D., Board
- Melissa Anagnostakos — Chief Operating Officer
- William Hunter — General Counsel
- Manru Wang — Chief of Staff
- Satya Ganti — Ph.D., Board, Portfolios
- Rajiv Savara — Board

## Questions

### What investment stages does 215 Capital target?

215 Capital invests from seed stage through late-stage growth. The approach is generalist across venture and expansion capital, with no publicly stated minimum or maximum check size. Their flexibility allows them to support companies from initial product development through scaling phases.

### Which sectors does 215 Capital focus on?

The firm concentrates on enterprise software, fintech, and digital health, with additional activity observed in AI/ML. They have not indicated a strict sector exclusion policy. No investments in hardware, industrials, or consumer goods have been identified.

## Related profiles

- [2150](https://altss.com/profile/2150)
- [216 Capital](https://altss.com/profile/216-capital)

---

Last updated: 2026-08-11T15:05:57.154Z

Canonical page: https://altss.com/profile/215-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology